Randomized controlled trial2015Industry fundedOpen access

Effects of daily almond consumption on cardiometabolic risk and abdominal adiposity in healthy adults with elevated LDL-cholesterol: a randomized controlled trial

Berryman CE, West SG, Fleming JA, Bordi PL, Kris-Etherton PM

Journal of the American Heart Association · 72 citations

Review labels

Author industry tiesControlled feedingIndustry funded

Neutral facts our review recorded about how this study was done. They describe method, never whether we like the result.

How it was studied

Design
Randomized controlled trial (indexed by PubMed)
Studied in
People
Main outcome
Health markers and function
Intake measured by
Food provided by researchers

Who paid for it

Funding
Industry funded
University or hospital
University of Pennsylvania
University or hospital
Pennsylvania State University
University or hospital
Deutsches Krebsforschungszentrum
Government
National Center for Research Resources
Government
NCRR NIH HHS
Authors
At least one author declares a financial tie to industry
Grants
National Center for Research Resources (M01 RR10732); National Center for Research Resources (M01-RR-010732)

Based on 5 listed funder(s) and full-text disclosure statement.

Publication

Published
2015-01-05 · J Am Heart Assoc · vol. 4 · issue 1 · p. e000993
Publisher
Wiley
Cited
114 citations · more than 97% of similar papers · 6.6× the field average
Impact
Top 10% most cited in its field
References
51 works
Access
Open access (journal) · CC-BY-NC
Research areas
Nuts composition and effects · Ginger and Zingiberaceae research · Peanut Plant Research Studies
Keywords
Medicine, Ldl cholesterol, Cholesterol, Randomized controlled trial, Abdominal obesity, Internal medicine, Metabolic syndrome, Endocrinology, Obesity
MeSH
humans, cardiovascular diseases, hypercholesterolemia, apolipoproteins, absorptiometry, photon, risk assessment, cross-over studies, reference values, adult, aged, middle aged, female, male, cholesterol, ldl, cholesterol, hdl, waist circumference, obesity, abdominal, healthy volunteers, prunus dulcis

5 authors

From US

  • Claire E. BerrymanPennsylvania State University
  • Sheila G. WestPennsylvania State University
  • Jennifer A FlemingPennsylvania State University
  • Peter L. BordiPennsylvania State University
  • Penny M. Kris‐Etherton · correspondingPennsylvania State University

Abstract

Background

Evidence consistently shows that almond consumption beneficially affects lipids and lipoproteins. Almonds, however, have not been evaluated in a controlled-feeding setting using a diet design with only a single, calorie-matched food substitution to assess their specific effects on cardiometabolic risk factors.

Methods and results

In a randomized, 2-period (6 week/period), crossover, controlled-feeding study of 48 individuals with elevated LDL-C (149±3 mg/dL), a cholesterol-lowering diet with almonds (1.5 oz. of almonds/day) was compared to an identical diet with an isocaloric muffin substitution (no almonds/day). Differences in the nutrient profiles of the control (58% CHO, 15% PRO, 26% total fat) and almond (51% CHO, 16% PRO, 32% total fat) diets were due to nutrients inherent to each snack; diets did not differ in saturated fat or cholesterol. The almond diet, compared with the control diet, decreased non-HDL-C (-6.9±2.4 mg/dL; P=0.01) and LDL-C (-5.3±1.9 mg/dL; P=0.01); furthermore, the control diet decreased HDL-C (-1.7±0.6 mg/dL; P<0.01). Almond consumption also reduced abdominal fat (-0.07±0.03 kg; P=0.02) and leg fat (-0.12±0.05 kg; P=0.02), despite no differences in total body weight.

Conclusions

Almonds reduced non-HDL-C, LDL-C, and central adiposity, important risk factors for cardiometabolic dysfunction, while maintaining HDL-C concentrations. Therefore, daily consumption of almonds (1.5 oz.), substituted for a high-carbohydrate snack, may be a simple dietary strategy to prevent the onset of cardiometabolic diseases in healthy individuals.

Clinical trial registration url

www.clinicaltrials.gov; Unique Identifier: NCT01101230.

Abstract via Europe PMC. Copyright remains with the authors or publisher (CC BY-NC).

Community trust

Loading…

How much do you trust this study's findings?

0 · not at all10 · completely

Comments

Sign in to rate, comment on or flag this study.Sign in

Something wrong here?

Flag this study if its information, labels or funding look wrong. An editor reviews every flag.

Sign in to rate, comment on or flag this study.Sign in

Educational information about published research. Not medical advice, and not a recommendation to start or stop anything.